Health & Safety Industry Today
Asthma And COPD Drugs Market to Reach USD 35.36 Billion by 2030, Driven by Increasing COPD Prevalence and Improved Inhalation Therapies
Introduction
The market for the Chronic Obstructive Pulmonary Disorder (COPD) treatment landscape frequently reported under the broader Asthma and COPD drugs market is gaining momentum. According to research from Mordor Intelligence, the Asthma and COPD Drugs Market size is valued at USD 27.58 billion in 2025 and is projected to expand to USD 35.36 billion by 2030, posting a 5.09% CAGR over the forecast period. This growth is being driven by a rising global burden of COPD, increasing prevalence of risk factors such as tobacco use and air-pollution, as well as advancing therapeutic options and improved access in emerging markets. The growing availability of inhaled therapies, once-daily fixed-dose combinations and novel biologics are enhancing patient management and adherence. The shift toward digital inhalers and connected monitoring also supports increased uptake. Regionally, while North America continues to command the largest share, Asia-Pacific is expected to grow fastest over the forecast period.
Key Trends
- Expansion of Healthcare Expenditure and Reimbursement for Respiratory Therapies in Emerging Markets
- Surge in Biologics and Targeted Therapy Approvals for Severe Uncontrolled Asthma
- Growing Adoption of Fixed-Dose Combination & Once-Daily Inhalers to Improve Patient Compliance
- Advancements in Inhaler Technologies Enhancing Drug Delivery
- High Treatment Costs of Biologics Limiting Access in Cost-Sensitive Regions
- Intensifying Generic Competition Following Key Inhaler Patent Expiries
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
By Drug Class
- Bronchodilators
- Anti-inflammatory Drugs
- Monoclonal Antibodies
- Combination Drugs
By Route of Administration
- Inhaled
- Oral
- Injectable / Parenteral
By Indication
- Asthma
- Chronic Obstructive Pulmonary Disease
By Prescription Type
- Prescription (Rx)
- Over the Counter (OTC)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geography Analysis
North America holds a strong position in the asthma and COPD drug landscape due to supportive healthcare systems and favorable regulatory policies that encourage novel treatments. The region faces ongoing discussions around drug affordability and patent reforms as high costs affect patient access, while Canada and Mexico each pursue distinct pricing and reimbursement strategies to expand care availability.
In Asia-Pacific, rising healthcare awareness and government-backed infrastructure investments are driving significant progress. Countries are enhancing domestic production while simultaneously embracing advanced treatments to meet growing respiratory health needs, making the region a key engine of market expansion.
Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk
Key Players
Leading global pharmaceutical companies such as GlaxoSmithKline PLC, AstraZeneca PLC, Boehringer Ingelheim GmbH, Novartis AG, and Teva Pharmaceutical Industries Ltd play a pivotal role in advancing healthcare. They hold strong portfolios across respiratory, oncology, and CNS therapies. With sustained R&D investments and biologics innovation, these firms maintain a competitive edge. Their global presence ensures broad access to essential and specialty medicines worldwide.
Trending Reports
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
